SBP solbec pharmaceuticals limited

?, page-2

  1. refresher
    2,381 Posts.
    lightbulb Created with Sketch. 429
    clock Created with Sketch.
    04/11/04
    10:54
    Post #: 641758
    psoriasis trial enters final stage... Solbec Pharmaceuticals Ltd (ASX:SBP) today announced
    the successful completion of the first two stages of the Phase I clinical trial of its lead compound,
    CoramsineTM (SBP002), for the treatment of psoriasis. The company has entered the third and
    final stage of the clinical trial which involves the testing of CoramsineTM on patients with
    psoriasis. Importantly for Solbec, the trial will monitor how well the psoriasis responds to treatment
    as well as any unwanted outcomes. Results should be out early 2005. Cancer results shouldn't be too far behind.
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RC1 Redcastle Delivers Positive Scoping Study for Queen Alexandra
right-arrow Created with Sketch.
NEWS Opportunities like this don’t last—register and get started today
right-arrow Created with Sketch.
NEWS Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises
right-arrow Created with Sketch.
NEWS The Watchlist - Hear from ASX Leaders!
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS Access all the latest ASX news here
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.